BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, Li CY, Su YR, Liu YR, Sang X, Wan Q, Liu C, Yang L, Wang ZC. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Prolif 2020;53:e12865. [PMID: 32588948 DOI: 10.1111/cpr.12865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 He J, Liu Z, Zhu X, Xia H, Gao H, Lu J. Ultrasonic Microbubble Cavitation Enhanced Tissue Permeability and Drug Diffusion in Solid Tumor Therapy. Pharmaceutics 2022;14:1642. [PMID: 36015267 DOI: 10.3390/pharmaceutics14081642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Liu B, Chen L, Huang H, Huang H, Jin H, Fu C. Prognostic and Immunological Value of GNB4 in Gastric Cancer by Analyzing TCGA Database. Dis Markers 2022;2022:7803642. [PMID: 35756485 DOI: 10.1155/2022/7803642] [Reference Citation Analysis]
3 Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev 2022;185:114300. [PMID: 35447165 DOI: 10.1016/j.addr.2022.114300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shi P, Liu Y, Yang H, Hu B. Breast cancer derived exosomes promoted angiogenesis of endothelial cells in microenvironment via circHIPK3/miR-124-3p/MTDH axis. Cell Signal 2022;:110338. [PMID: 35460835 DOI: 10.1016/j.cellsig.2022.110338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yi J, Zhong W, Wu H, Feng J, Zouxu X, Huang X, Li S, Shuang Z. Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer. Front Oncol 2021;11:746058. [PMID: 34745969 DOI: 10.3389/fonc.2021.746058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Syama K, Hassan EM, Zou S. Advances in culture methods for acute myeloid leukemia research. Oncoscience 2021;8:82-90. [PMID: 34368398 DOI: 10.18632/oncoscience.540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cao L, Li W, Yang X, Zhang W, Li M, Zhang H, Qin C, Chen X, Gao R. Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment. Cancer Gene Ther 2021. [PMID: 34158625 DOI: 10.1038/s41417-021-00354-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kronemberger GS, Miranda GASC, Tavares RSN, Montenegro B, Kopke ÚA, Baptista LS. Recapitulating Tumorigenesis in vitro: Opportunities and Challenges of 3D Bioprinting. Front Bioeng Biotechnol 2021;9:682498. [PMID: 34239860 DOI: 10.3389/fbioe.2021.682498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
9 Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther 2021;6:72. [PMID: 33608497 DOI: 10.1038/s41392-020-00449-4] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 74.0] [Reference Citation Analysis]
10 Wang Z, Su G, Dai Z, Meng M, Zhang H, Fan F, Liu Z, Zhang L, Weygant N, He F, Fang N, Zhang L, Cheng Q. Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation. Cell Prolif 2021;54:e12988. [PMID: 33442944 DOI: 10.1111/cpr.12988] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 23.0] [Reference Citation Analysis]
11 Narayan S. Challenges and Future Opportunities of Nanomedicine in Cancer Therapy. Nanomedicine for Cancer Diagnosis and Therapy 2021. [DOI: 10.1007/978-981-15-7564-8_10] [Reference Citation Analysis]
12 Galván Morales MA, Barrera Rodríguez R, Santiago Cruz JR, Teran LM. Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy. Molecules 2020;25:E5686. [PMID: 33276556 DOI: 10.3390/molecules25235686] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
13 Gray M, Meehan J, Turnbull AK, Martínez-Pérez C, Kay C, Pang LY, Argyle DJ. The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology. Front Vet Sci 2020;7:598338. [PMID: 33282935 DOI: 10.3389/fvets.2020.598338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Mccormick K, Sanitt P, Fan S, Mason JD, Harris AL, Hamdy FC, Verrill C, Bryant RJ, Goberdhan DCI. Anti-androgens induce Rab11a-exosome secretion in prostate cancer by suppressing amino acid-sensitive PAT4-mTORC1 signalling.. [DOI: 10.1101/2020.09.18.300137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Golubovskaya V, Bukrinsky MI, Grizzi F. Editorial On "Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy". Vaccines (Basel) 2020;8:E421. [PMID: 32731435 DOI: 10.3390/vaccines8030421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, Li CY, Su YR, Liu YR, Sang X, Wan Q, Liu C, Yang L, Wang ZC. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Prolif 2020;53:e12865. [PMID: 32588948 DOI: 10.1111/cpr.12865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]